Changes in Mfn2 expression due to altered glucose oxidation in conditions such as diabetes, obesity, insulin resistance, exercise and weight loss, have been demonstrated both in vitro and in vivo (Bach et al.,2003; Pich et al.,2005). This evidence concerns the gene MFN2 and obesity due to melanocortin 4 receptor deficiency.